Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment
Journal of Pharmaceutical Analysis · 2025-01 · 15 (1) · 101099
DOI: 10.1016/j.jpha.2024.101099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-01. Verfasst von Zhengping Che und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Chongqing University, Chongqing, 401331, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Gastrointestinal (GI) cancers are prevalent globally, with leading incidence and mortality rates among malignant tumors. Despite notable advancements in surgical resection, radiotherapy, and chemotherapy, the overall survival rates remain low. Hence, it is imperative to explore alternative approaches that enhance patient outcomes. Cluster of differentiation 47 (CD47), serving as an early diagnostic marker, is predominantly overexpressed in GI cancers and associated with poor prognosis. Targeting the CD47-signal regulatory protein alpha (SIRPα) signaling pathway may provide a novel strategy for GI cancers treatment. This study summarizes current knowledge of the structure and function of CD47 and SIRPα, their roles in signaling pathways, the prognostic significance of CD47, therapeutic strategies targeting the CD47-SIRPα signaling pathway in GI cancer, and highlights key issues for future investigations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Chongqing University, Chongqing, 401331, China.
- Department of Cancer Center, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing, 404000, China.
- Department of Gastroenterology, Chongqing University Jiangjin Hospital, Chongqing, 402260, China.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
Zitieren
APA
Che, Z., Wang, W., Zhang, L., & Lin, Z. (2025). Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment. Journal of Pharmaceutical Analysis, 15(1), 101099. https://doi.org/10.1016/j.jpha.2024.101099
Vancouver
Che Z, Wang W, Zhang L, Lin Z. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment. Journal of Pharmaceutical Analysis. 2025;15(1):101099. doi:10.1016/j.jpha.2024.101099
BibTeX
@article{Che2025,
author = {Che, Zhengping and Wang, Wei and Zhang, Lin and Lin, Zhenghong},
title = {Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {1},
pages = {101099},
doi = {10.1016/j.jpha.2024.101099}
}
EUVIMED